Free Trial

Cidara Therapeutics (CDTX) SEC Filings & 10K Form

Cidara Therapeutics logo
$67.49 +2.46 (+3.78%)
Closing price 04:00 PM Eastern
Extended Trading
$68.24 +0.75 (+1.11%)
As of 05:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Cidara Therapeutics SEC Filings

DateFilerForm TypeView
08/14/2025
4:59 PM
Cidara Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SCHEDULE 13G/A
08/14/2025
4:28 PM
Cidara Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SCHEDULE 13G/A
08/12/2025
7:50 PM
Cidara Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
Form SCHEDULE 13G/A
08/12/2025
8:02 AM
Adage Capital Management, L.P. (Filed by)
Cidara Therapeutics (Subject)
Form SCHEDULE 13G/A
07/17/2025
7:12 PM
BlackRock, Inc. (Filed by)
Cidara Therapeutics (Subject)
Form SCHEDULE 13G
07/02/2025
3:32 PM
Cidara Therapeutics (Subject)
Commodore Capital LP (Filed by)
Form SCHEDULE 13G
06/30/2025
4:05 PM
Cidara Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SCHEDULE 13D/A
06/25/2025
3:35 PM
Cidara Therapeutics (Filer)
Form 424B5
06/25/2025
3:39 PM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2025
4:18 PM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/23/2025
4:30 PM
Cidara Therapeutics (Filer)
Form 424B5
06/23/2025
6:05 AM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2025
3:37 PM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2025
4:20 PM
Cidara Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2025
11:15 PM
Cidara Therapeutics (Filer)
Form EFFECT
05/15/2025
4:47 PM
Cidara Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SCHEDULE 13G/A
05/15/2025
7:31 AM
Cidara Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
Form SCHEDULE 13G/A
05/12/2025
7:37 PM
Cidara Therapeutics (Issuer)
Davarpanah Nicole Negar (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/12/2025
7:40 PM
Cidara Therapeutics (Issuer)
Davarpanah Nicole Negar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2025
8:04 AM
Adage Capital Management, L.P. (Filed by)
Cidara Therapeutics (Subject)
Form SCHEDULE 13G
05/08/2025
4:25 PM
Cidara Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/15/2025
4:27 PM
Cidara Therapeutics (Filer)
Form PRE 14A
04/02/2025
5:27 PM
Cidara Therapeutics (Issuer)
Ward Shane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
5:28 PM
Cidara Therapeutics (Issuer)
Stein Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2025
5:34 PM
Cidara Therapeutics (Issuer)
Ward Shane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2025
5:33 PM
Cidara Therapeutics (Issuer)
Tari Leslie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:40 PM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2025
3:52 PM
Cidara Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/26/2025
5:31 PM
Cidara Therapeutics (Issuer)
KARBE FRANK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
5:24 PM
Cidara Therapeutics (Issuer)
KARBE FRANK (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/07/2025
5:29 PM
Cidara Therapeutics (Issuer)
Resnick Joshua (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/07/2025
5:38 PM
Cidara Therapeutics (Issuer)
Resnick Joshua (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
4:42 PM
Cidara Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
4:12 PM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2025
3:02 PM
Cidara Therapeutics (Filer)
Form 424B3
01/01/2025
11:15 PM
Cidara Therapeutics (Filer)
Form EFFECT
12/23/2024
3:39 PM
Cidara Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
12/19/2024
5:15 PM
Canale-Theakston Carin (Reporting)
Cidara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
5:17 PM
Bassler Bonnie L (Reporting)
Cidara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
5:18 PM
Cidara Therapeutics (Issuer)
Mineo Chrysa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
5:19 PM
Cidara Therapeutics (Issuer)
Schroeder Theodore R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
What Steve Bannon revealed about Trump’s gold play (Ad)

A Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your IRA could be at risk. Here’s how to prepare.tc pixel

Download the Free Gold Protection Guide to get started now
12/19/2024
5:20 PM
BURGESS DANIEL D (Reporting)
Cidara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
4:37 PM
Cidara Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
Form SC 13G
12/03/2024
3:34 PM
Cidara Therapeutics (Subject)
TCG Crossover GP II, LLC (Filed by)
Form SC 13G
11/29/2024
3:15 PM
Cidara Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
4:32 PM
Cidara Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13D/A
10/02/2024
4:19 PM
Cidara Therapeutics (Issuer)
Shah Preetam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
4:25 PM
Cidara Therapeutics (Issuer)
Stein Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
4:27 PM
Cidara Therapeutics (Issuer)
Tari Leslie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
4:30 PM
Cidara Therapeutics (Issuer)
Sandison Taylor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2024
7:10 AM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2024
5:26 PM
Cidara Therapeutics (Issuer)
Tari Leslie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
5:27 PM
Cidara Therapeutics (Issuer)
Sandison Taylor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:18 PM
Cidara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CDTX) was last updated on 8/21/2025 by MarketBeat.com Staff
From Our Partners